Press Release - A drug currently approved for smallpox in the U.S. will undergo clinical trials to treat patients infected by the Mpox viruswho are at risk of severe complications in the Democratic ...

The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

The Frederick biotechnology company BioFactura has announced $7.8 million in new contract activations to study a treatment for a potential smallpox outbreak. The company has gotten contract option ...

(KTAL/KMSS) – Just prior to the Louisiana Purchase, early settlers in Mississippi and Louisiana had the ability to vaccinate ...

South Korea carried out its first pan-government exercise to test its preparedness against a potential bioterrorist attack ...

Smallpox, typhoid, and yellow fever were the most dreaded scourges of the 19th century. They seemed to come out of nowhere, ...

WHO’S SHOWING UP EARLY? Trump had better hope that his—ah— unorthodox appeal to female voters is paying off. Politico reports ...

To win American independence, he not only had to defeat the British army; he had to defeat smallpox. At the time, 90% of deaths in the Continental Army were due to disease. Smallpox was so feared ...

Britain is mounting a major pre-emptive strike against smallpox attack by germ war terrorists. Up to 60million doses of the vaccine are being stockpiled, enough to treat the entire population.

Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

Emergent BioSolutions says its smallpox treatment to be evaluated in mpox trial in Africa. On Thursday, Emergent BioSolutions Inc. EBS stock is trading higher on mixed third-quarter earnings and a new ...